Part 3: Regulatory Integrity and the Assessment of Vaccine Safety and Efficacy

Part 3: Regulatory Integrity and the Assessment of Vaccine Safety and Efficacy

Preserving the Scientific Integrity of Getting to COVID-19 Vaccines: From Clinical Trials to Public Allocation